Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Manufacturing
FDA slams 3 Indian drugmakers in flurry of recent Form 483s
The FDA hit three Indian drugmakers with Form 483s after inspections uncovered unsanitary conditions, broken equipment and poor recordkeeping.
Joseph Keenan
Apr 16, 2024 8:45am
FDA advisers back new endpoint for myeloma approvals
Apr 12, 2024 4:06pm
House Oversight Committee grills FDA's Robert Califf at hearing
Apr 12, 2024 8:49am
Jubilant Generics, Contract Pharmaceuticals hit with Form 483s
Apr 9, 2024 8:22am
Many meds couldn't prove benefits after speedy FDA nods: study
Apr 8, 2024 6:30pm
House committee to question FDA's Califf on shortage oversight
Apr 5, 2024 10:14am